LSTA Q1 2018 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-7.82

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$146,533

Balance Sheet

Total Assets

$57M

Total Liabilities

$11M

Stockholders' Equity

$46M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$8M	-100.0%
Gross Profit	$0	-$120,000	+100.0%
Operating Income	-$5M	-$6M	+19.8%
Net Income	-$5M	-$9M	+46.8%